Every Form 4 that Procter & Gamble (PG) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A Form 4 covers the transactions officers, directors and large holders report, so if you follow PG and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full PG filings page.
Jennifer L. Davis, an officer (CEO - Health Care) of Procter & Gamble Co (PG), reported a sale of 3,227 shares of common stock on 10/02/2025. The shares were sold at a reported price of $152.2317 and were sold to cover a tax obligation upon settlement of a Restricted Stock Unit award. After the transaction, the filing shows 61,763.9326 shares held directly and 15,535.3029 shares held indirectly through a retirement plan trustee, for combined beneficial ownership disclosed on the form.
The sale is described as a routine disposition to satisfy taxes tied to equity compensation rather than an open-market divestiture for liquidity. The form is signed by an attorney-in-fact and reports the transaction under Section 16 rules for insiders.
Insider sale to cover taxes following RSU settlement: An officer of Procter & Gamble (PG) reported a disposition of 3,535 shares of common stock on 10/02/2025 at a price of $152.2317 per share. After the sale, the reporting person holds 34,816.145 shares directly and additionally reports indirect holdings of 481.8949 shares (retirement plan trustee) and 1,295.35 shares (international plans).
The filing states the shares were sold to cover tax obligations upon settlement of a Restricted Stock Unit award, and the Form 4 was signed by an attorney-in-fact on 10/06/2025. This is a routine, compliance-driven transaction that reduced direct beneficial ownership by a measurable amount.
Susan Street Whaley, Chief Legal Officer & Secretary of Procter & Gamble Co (PG), reported an insider sale on 10/02/2025. The filing shows 2,408 shares of common stock were sold at a price of $152.2317 per share to cover taxes on a prior restricted stock unit grant.
After the transaction, Ms. Whaley beneficially owned 31,769.8354 shares directly and an additional 6,531.6011 shares indirectly through a retirement plan trustee. The Form 4 was signed by an attorney-in-fact on 10/06/2025, and the filing indicates compliance with Section 16 reporting requirements.
Susan Street Whaley, Chief Legal Officer & Secretary of Procter & Gamble Co (PG), reported insider acquisitions on 10/01/2025. She acquired 5,742 shares through restricted stock units awarded under the company plan and recorded 26,531 stock option rights with an exercise/conversion price of $153.18, exercisable beginning 09/29/2028 and expiring 10/01/2035. After the transactions, Ms. Whaley beneficially owns 34,177.8354 shares directly and 6,531.6011 shares indirectly through a retirement plan trustee. The Form 4 was signed by an attorney-in-fact on 10/02/2025.
Raman Sundar G., listed as CEO-Fabric & Home Care at Procter & Gamble Co (PG), filed a Form 4 reporting transactions dated 10/01/2025. The filing shows a disposition of 41,886.4892 shares of common stock and an indirect beneficial ownership interest of 8,436.9135 shares held by a retirement plan trustee.
The filing also reports a derivative transaction dated 10/01/2025 labeled as an acquisition: a stock option with a $153.18 exercise/conversion price tied to 68,869 underlying common shares (listed as 68,869 shares beneficially owned following the transaction). An explanatory note states this reflects an adjustment to PST through September 30, 2025. The form is signed by an attorney-in-fact on 10/02/2025.
Gary A. Coombe, identified as CEO - Grooming and an officer of Procter & Gamble Co (PG), reported transactions on 10/01/2025. He was awarded 3,373 Restricted Stock Units under the 2019 Stock and Incentive Compensation Plan, increasing his direct beneficial ownership to 38,351.145 shares. The filing also shows indirect holdings of 481.8949 shares via a retirement plan trustee and 1,295.35 shares through an International Stock Ownership & Pension Plan (Switzerland). In derivatives, Mr. Coombe acquired 46,754 stock options with an exercise price of $153.18, exercisable beginning 09/29/2028 and expiring 10/01/2035. The form was signed by Wednesday Shipp as attorney-in-fact on 10/02/2025.
Ma. Fatima Francisco, an officer at Procter & Gamble Co (PG), reported transactions dated 10/01/2025. The filing shows a disposition of 27,295.0856 shares of Common Stock and an acquisition via option exercise of 62,338 shares (stock option with exercise price $153.18), resulting in 62,338 shares held directly after the exercise. Post-transaction indirect holdings include 15,998.3673 shares held by a retirement plan trustee and 2,862.8125 shares held indirectly by spouse and plan trustees. The form includes an explanatory note that the figures reflect an adjustment to PST through September 30, 2025. The report is signed by an attorney-in-fact on 10/02/2025.
Jennifer L. Davis, listed as CEO - Health Care at Procter & Gamble (PG), reported transactions dated 10/01/2025. The Form 4 shows a disposition of 64,990.9326 shares of common stock and an indirect holding of 15,535.3029 shares held by a retirement plan trustee. The filing also reports an acquisition of 68,869 stock options at an exercise price of $153.18; those options are listed as exercisable beginning 09/29/2028 with an expiration date of 10/01/2035.
The form includes an explanatory note that the indirect amount reflects an adjustment to the participant service trust through 09/30/2025. The document is signed on behalf of Ms. Davis by an attorney-in-fact on 10/02/2025. All items reported are changes in beneficial ownership as required under Section 16.
Matthew W. Janzaruk, SVP and Chief Accounting Officer of Procter & Gamble Co (PG), reported transactions dated 10/01/2025. He exercised_stock_options to acquire 13,779 shares (stock option exercise price $153.18) and directly holds those 13,779 shares following the exercise. The Form 4 also shows a sale of 1,703.9031 shares on the same date and reports 3,293.5342 shares beneficially owned indirectly via a retirement plan trustee after an adjustment through 9/30/2025. The filing was signed by an attorney-in-fact on 10/02/2025. The report is an insider disclosure of option exercise, a small open-market sale, and an adjustment to retirement-plan holdings; it contains transaction dates, amounts, and the exercise price but no cash proceeds or reasons for the transactions.
Procter & Gamble officer Keith R. Alexandra reported changes in beneficial ownership on a Form 4 covering transactions dated 10/01/2025. The filing shows a disposition of 27,529.5056 shares of common stock and indirect holdings reported as 4,479.8913, 4,895.7069, and 2,594.244 shares held via spouse and retirement plan trustee arrangements. The filing also reports two stock option acquisitions executed on 10/01/2025: 62,338 options exercisable from 09/29/2028 through 10/01/2035 (direct) and 14,163 options with the same exercisability and expiration terms (indirect by spouse). An explanatory note states the spouse/plan amounts reflect an adjustment through 09/30/2025. The form is signed by an attorney-in-fact on 10/02/2025.
Balaji Purushothaman, Chief Human Resources Officer of Procter & Gamble (PG), reported transactions on 09/15/2025. The filing shows a disposition of 13,106.0044 shares of common stock and an acquisition by exercise of a stock option (right to buy) for 11,420 shares with a stated exercise price of $156.83. The filing also discloses 5,112.6018 shares held indirectly through a retirement plan trustee. The Form 4 was signed by an attorney-in-fact on 09/17/2025.
Shailesh Jejurikar, Chief Operating Officer of Procter & Gamble Co (PG), reported transactions dated 09/15/2025. The filing shows a disposition of 28,036.3817 shares of Common Stock and the acquisition of a stock option award for 26,231 underlying shares with an exercise price of $156.83. The option award is listed as acquired on 09/15/2025, becomes exercisable on 09/15/2028 and expires 09/14/2035. The report lists indirect beneficial ownership stakes of 3,301.9815 shares held by a retirement plan trustee, 19,757 shares held by the Sankhya S Jejurikar Revocable Trust, and 17,849 shares held by the Shailesh Jejurikar Trust. The form is signed by an attorney-in-fact on 09/17/2025.
Reporting person: Aguilar Moses Victor Javier, Chief Research, Development & Innovation Officer at Procter & Gamble Co (PG). Transactions on 09/15/2025: the Form 4 discloses a disposition of 40,841.1704 shares of P&G common stock and continuing indirect holdings of 6,750.7456 shares held by a Retirement Plan Trustee and 428.6033 shares held by an International Stock Ownership Plan (Mexico) Trustee. The filing also reports an acquisition (transaction code A) of 6,852 stock options tied to 6,852 underlying common shares with a stated conversion/exercise price of $156.83 and a listed price of $0; the options show exercisability beginning 09/15/2028 and expiration 09/14/2035. The form is signed by an attorney-in-fact on behalf of Mr. Aguilar on 09/17/2025.